Sources Reveal Biogen is Exploring Sale of Hemophilia Assets Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By Mark Terry, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like GlaxoSmithKline to Shift Neuro R&D Out of China to Philadelphia Research Hub August 3, 2017 Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC September 14, 2017 PPD Clinical Research Associates Recognized For Excellence June 8, 2017
